| 2025-11-04 |
详情>>
股本变动：
变动后总股本7468.19万股
变动原因 ▼▲
- 原因：
- From June 30, 2025 to September 30, 2025
Common stock issued upon exercise of stock options
|
| 2025-11-04 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-0.04美元,归母净利润-296.2万美元,同比去年增长94.10%
|
| 2025-11-04 |
财报披露：
美东时间 2025-11-04 盘后发布财报
|
| 2025-08-07 |
详情>>
业绩披露：
2025年中报每股收益0.10美元,归母净利润719.50万美元,同比去年增长172.22%
|
| 2025-06-04 |
详情>>
内部人交易：
Jones William Benton股份增加19357.00股
|
| 2025-05-08 |
详情>>
业绩披露：
2025年一季报每股收益0.21美元,归母净利润1519.30万美元,同比去年增长366.50%
|
| 2025-04-25 |
股东大会：
将于2025-06-12召开股东大会
会议内容 ▼▲
- 1.To elect two Class III Directors with terms to expire at the 2028 annual meeting of stockholders;
2.To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2025;
3.To approve, on a non-binding advisory basis, the compensation of the Company’s named executive officers as disclosed in the proxy statement accompanying this Notice of Annual Meeting of Stockholders;
4.To conduct any other business properly brought before the Annual Meeting.
|
| 2025-03-25 |
详情>>
业绩披露：
2022年年报每股收益-0.89美元,归母净利润-4130.7万美元,同比去年增长4.47%
|
| 2025-03-25 |
详情>>
业绩披露：
2024年年报每股收益-1.02美元,归母净利润-6229.3万美元,同比去年增长-130.47%
|
| 2024-11-12 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-0.86美元,归母净利润-5018万美元,同比去年增长-146.27%
|
| 2024-08-06 |
详情>>
业绩披露：
2023年中报每股收益-0.31美元,归母净利润-1437.6万美元,同比去年增长13.71%
|
| 2024-08-06 |
详情>>
业绩披露：
2024年中报每股收益-0.18美元,归母净利润-996.3万美元,同比去年增长30.70%
|
| 2024-05-07 |
详情>>
业绩披露：
2024年一季报每股收益-0.12美元,归母净利润-570.1万美元,同比去年增长27.59%
|
| 2024-04-26 |
股东大会：
将于2024-06-13召开股东大会
会议内容 ▼▲
- 1.To elect one Class II Director with term to expire at the 2027 annual meeting of stockholders;
2.To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2024;
3.To approve, on a non-binding advisory basis, the compensation of the Company’s named executive officers as disclosed in the proxy statement accompanying this Notice of Annual Meeting of Stockholders;
4.To conduct any other business properly brought before the Annual Meeting.
|
| 2024-03-19 |
详情>>
业绩披露：
2023年年报每股收益-0.56美元,归母净利润-2702.9万美元,同比去年增长34.57%
|
| 2023-11-07 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-0.43美元,归母净利润-2037.6万美元,同比去年增长35.30%
|
| 2023-04-28 |
股东大会：
将于2023-06-15召开股东大会
会议内容 ▼▲
- 1.To elect two Class I Directors with terms to expire at the 2026 annual meeting of stockholders;
2.To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2023;
3.To approve, on a non-binding advisory basis, the compensation of the Company’s named executive officers as disclosed in the proxy statement accompanying this Notice of Annual Meeting of Stockholders;
4.To conduct any other business properly brought before the Annual Meeting.
|
| 2022-04-28 |
股东大会：
将于2022-06-15召开股东大会
会议内容 ▼▲
- 1.To elect three Class III Directors with terms to expire at the 2025 annual meeting of stockholders;
2.To elect three Class III Directors with terms to expire at the 2025 annual meeting of stockholders;
3.To approve, on a non-binding advisory basis, the compensation of the Company’s named executive officers as disclosed in the proxy statement accompanying this Notice of Annual Meeting of Stockholders;
4.To hold a non-binding advisory vote on the frequency of future advisory votes by stockholders on the compensation of the Company’s named executive officers;
5.To conduct any other business properly brought before the Annual Meeting.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-07-16 |
复牌提示：
2021-07-15 16:00:37 停牌，复牌日期 2021-07-15 16:35:00
|
| 2021-04-20 |
股东大会：
将于2021-06-15召开股东大会
会议内容 ▼▲
- 1.To elect two Class II Directors with terms to expire at the 2024 annual meeting of stockholders;
2.To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2021;
3.To conduct any other business properly brought before the Annual Meeting.
|
| 2020-04-15 |
股东大会：
将于2020-06-09召开股东大会
会议内容 ▼▲
- 1.To elect two Class I Directors with terms to expire at the 2023 annual meeting of stockholders;
2.To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2020;
3.To conduct any other business properly brought before the Annual Meeting.
|
| 2019-04-24 |
股东大会：
将于2019-06-20召开股东大会
会议内容 ▼▲
- 1.To elect three Class III Directors with terms to expire at the 2022 annual meeting of stockholders;
2.To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2019;
3.To conduct any other business properly brought before the Annual Meeting.
|
| 2018-04-27 |
股东大会：
将于2018-06-21召开股东大会
会议内容 ▼▲
- 1.To elect two Class II Directors with terms to expire at the 2021 annual meeting of stockholders;
2.To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2018;
3.To conduct any other business properly brought before the Annual Meeting.
|
| 2017-04-24 |
股东大会：
将于2017-06-08召开股东大会
会议内容 ▼▲
- 1.To elect two Class I Directors with terms to expire at the 2020 annual meeting of stockholders;
2.To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2017;
3.To ratify the Corvus Pharmaceuticals, Inc. Amended and Restated Certificate of Incorporation (our "Charter");
4.To ratify the Corvus Pharmaceuticals, Inc. Amended and Restated Bylaws (our "Bylaws");
5.To conduct any other business properly brought before the Annual Meeting.
|